Dockets: 2004N-0033 Factor VIII Inhibitors, Public Workshop

2004N-0033 - Factor VIII Inhibitors, Public Workshop

Item Code	No.	Received Date	Submitter	Signature	FR Date	FR Page	Electronic form
N	1				07/06/2004	40639	pdf htm
C	2	03/15/2004	Bayer HealthCare LLC	Carol M Moore			pdf
C	1	03/12/2004	Wyeth Pharmaceuticals	Robin Evers			pdf
EC	1	02/07/2004	Number not used
TR	1	01/30/2004	Transcript of the 11/21/2003 Workshop				pdf
TS	17	01/30/2004	D DiMichele MD	Donna DiMichele MD			pdf
TS	16	01/30/2004	Wyeth	Jay M Feingold, MD PhD			pdf
TS	15	01/30/2004	Octagen Corporation				pdf
TS	14	01/30/2004	Bayer HealthCare	Peter Larson MD			pdf
TS	13	01/30/2004	B Ewenstein MD PhD	B Ewenstein MD PhD			pdf
TS	12	01/30/2004	L Aledort MD	Louis Aledort MD			pdf
TS	11	01/30/2004	Tie-Hua Ng, PhD	Tie-Hua Ng, PhD			pdf
TS	10	01/30/2004	FDA, Center for Biologics Research and Evaluation	Nicha Jain MD			pdf
TS	9	01/30/2004	Paul Ehrlich Institute	Rainer Seitz MD			pdf
TS	8	01/30/2004	National Center on Birth Defects and Development Disabilities				pdf
TS	7	01/30/2004	Association of Hemophilia Clinic Directors of Canada (AHCDC)	Manuel Carcao et al			pdf
TS	6	01/30/2004	G White MD	Gilbert White MD			pdf
TS	5	01/30/2004	B Verbruggen	Bert Verbruggen			pdf
TS	4	01/30/2004	S Raut	Sanj Raut			pdf
TS	3	01/30/2004	J Remy MD PhD	Jean-Marie R Saint-Remy MD PhD			pdf
TS	2	01/30/2004	FDA, Center for Biologics Research and Evaluation	Jay Lozier, MD PhD			pdf
TS	1	01/30/2004	FDA, Center for Biologics Research and Evaluation	Jay Epstein, MD			pdf
M	1	01/29/2004	FDA, Center for Biologics Research and Evaluation to Dockets	Mark Weinstein PhD			pdf Word htm

Page created July 15, 2004 jb
Page last updated July 15, 2004 kk